Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma

RYO SATO; YUTO MATSUSHITA; AYANA TAKEMURA; MOMOKO SUGIYAMA; KYOHEI WATANABE; HIROMITSU WATANABE; KEITA TAMURA; DAISUKE MOTOYAMA; MASAO NAGATA; ATSUSHI OTSUKA; HIROSHI FURUSE; HIDEAKI MIYAKE

doi:10.21873/anticanres.16869

Research ArticleClinical Studies

Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma

RYO SATO, YUTO MATSUSHITA, AYANA TAKEMURA, MOMOKO SUGIYAMA, KYOHEI WATANABE, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, MASAO NAGATA, ATSUSHI OTSUKA, HIROSHI FURUSE and HIDEAKI MIYAKE

Anticancer Research February 2024, 44 (2) 781-786; DOI: https://doi.org/10.21873/anticanres.16869

RYO SATO

1Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: rsato02{at}hama-med.ac.jp

YUTO MATSUSHITA

1Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

AYANA TAKEMURA

1Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MOMOKO SUGIYAMA

2Department of Urology, Seirei Mikatahara General Hospital, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KYOHEI WATANABE

1Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIROMITSU WATANABE

1Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KEITA TAMURA

1Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DAISUKE MOTOYAMA

3Department of Developed Studies for Advanced Robotic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MASAO NAGATA

4Department of Urology, Hamamatsu Medical Center, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

ATSUSHI OTSUKA

1Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIROSHI FURUSE

2Department of Urology, Seirei Mikatahara General Hospital, Hamamatsu, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIDEAKI MIYAKE

5Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

PreviousNext

In this issue

Anticancer Research

Vol. 44, Issue 2

February 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 3 + 3 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma

RYO SATO, YUTO MATSUSHITA, AYANA TAKEMURA, MOMOKO SUGIYAMA, KYOHEI WATANABE, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, MASAO NAGATA, ATSUSHI OTSUKA, HIROSHI FURUSE, HIDEAKI MIYAKE

Anticancer Research Feb 2024, 44 (2) 781-786; DOI: 10.21873/anticanres.16869

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma

RYO SATO, YUTO MATSUSHITA, AYANA TAKEMURA, MOMOKO SUGIYAMA, KYOHEI WATANABE, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, MASAO NAGATA, ATSUSHI OTSUKA, HIROSHI FURUSE, HIDEAKI MIYAKE

Anticancer Research Feb 2024, 44 (2) 781-786; DOI: 10.21873/anticanres.16869

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

No citing articles found.

Google Scholar

Keywords

Renal cell carcinoma
cabozantinib
adverse event
progression-free survival

Main menu

User menu

Search

Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma

Purchase access

patientACCESS

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords